These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 20881897

  • 1. Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas.
    Nagai S, Fujii T, Kodera Y, Kanda M, Sahin TT, Kanzaki A, Yamada S, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakao A.
    Pancreas; 2011 Jan; 40(1):3-9. PubMed ID: 20881897
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K, Meyer F, Schmidt U, Lippert H.
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [Abstract] [Full Text] [Related]

  • 8. The impact of obesity on outcomes following pancreatectomy for malignancy.
    Benns M, Woodall C, Scoggins C, McMasters K, Martin R.
    Ann Surg Oncol; 2009 Sep; 16(9):2565-9. PubMed ID: 19557479
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
    Zhou GW, Wu WD, Xiao WD, Li HW, Peng CH.
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma.
    Tsutsumi S, Morohashi S, Kudo Y, Akasaka H, Ogasawara H, Ono M, Takasugi K, Ishido K, Hakamada K, Kijima H.
    J Surg Oncol; 2011 Jun 01; 103(7):669-73. PubMed ID: 21360711
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H.
    Clin Cancer Res; 2008 Nov 01; 14(21):7043-9. PubMed ID: 18981001
    [Abstract] [Full Text] [Related]

  • 16. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
    Waraya M, Yamashita K, Katagiri H, Ishii K, Takahashi Y, Furuta K, Watanabe M.
    Ann Surg Oncol; 2009 May 01; 16(5):1231-40. PubMed ID: 19263172
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J, Centeno BA, Coppola D, Melis M, Lloyd M, Park JY, Chen DT, Malafa MP.
    Cancer; 2009 Sep 15; 115(18):4080-9. PubMed ID: 19626671
    [Abstract] [Full Text] [Related]

  • 19. A and B blood group antigens in human pancreatic ductal adenocarcinomas.
    Handra-Luca A.
    Oncology; 2013 Sep 15; 84(3):141-9. PubMed ID: 23257765
    [Abstract] [Full Text] [Related]

  • 20. Adverse oncologic effects of intraoperative transfusion during pancreatectomy for left-sided pancreatic cancer: the need for strict transfusion policy.
    Hwang HK, Jung MJ, Lee SH, Kang CM, Lee WJ.
    J Hepatobiliary Pancreat Sci; 2016 Aug 15; 23(8):497-507. PubMed ID: 27295957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.